Zoetis Inc. projects revenue growth between two percent and five percent for fiscal year 2026 as demand for companion-animal products in the U.S. softens [1].
The guidance indicates a cooling trend in the domestic pet-care market, a primary driver for the company's financial performance. This shift forces the animal health leader to lean more heavily on its global operations to maintain growth.
During a Q1 2026 earnings call on Thursday, CEO and Director Kristin Peck said there was a stagnation in domestic performance. On an organic operational basis, U.S. revenue was flat [1]. The company reported that adjusted net income grew by one percent during the first quarter [1].
While the U.S. market struggled, the company's global reach provided a buffer. "Our International segment delivered 10% organic operational revenue growth," Peck said [1]. This disparity suggests that the demand slump is concentrated within the U.S. companion-animal sector rather than being a systemic global decline.
Analysts said that the revised 2026 guidance reflects the challenge of maintaining high growth rates in a saturated or softening domestic market. The company's reliance on the international segment has become a critical component of its strategy to offset the 0% organic revenue growth seen in the U.S. this quarter [1].
Peck said that the company continues to monitor consumer spending patterns, and veterinary visit frequencies. The projected two percent to five percent increase for the full year remains a modest outlook compared to previous growth cycles [1].
“"Our International segment delivered 10% organic operational revenue growth."”
The softening of the U.S. companion-animal market suggests a potential shift in consumer spending on pet healthcare, possibly due to economic pressures or a post-pandemic correction in pet ownership levels. By relying on a 10% growth rate in international markets, Zoetis is diversifying its risk, but the flat domestic growth indicates that the company's primary market is reaching a plateau.
